why choose us

First received: November 13, 2023

Clinical Trial: Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: SLE (Systemic Lupus)

Study Type: INTERVENTIONAL


Official Title: Safety/Phase I Study of PiggyBac Transposon Mediated Chimeric Antigen Receptor T Cells Targeting CD-19 in Thai Patients With Refractory Systemic Lupus Erythematosus

Brief Summary: A Phase 1 clinical trial to evaluate the safety and efficacy of PiggyBac transposon-mediated Chimeric Antigen Receptor(CAR) T-cells targeting CD19 in refractory Systemic Lupus Erythematosus (SLE) patients who have not responded to standard immunosuppressive treatments.

Read more